Cargando…
Control of the innate immune response by the mevalonate pathway
Deficiency of mevalonate kinase (MVK) causes systemic inflammation. However, the molecular mechanisms linking the mevalonate pathway to inflammation remain obscure. Geranylgeranyl pyrophosphate (GGPP), a non-sterol intermediate of the mevalonate pathway, is the substrate for protein geranylgeranylat...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955724/ https://www.ncbi.nlm.nih.gov/pubmed/27270400 http://dx.doi.org/10.1038/ni.3487 |
_version_ | 1782443954145329152 |
---|---|
author | Akula, Murali K. Shi, Man Jiang, Zhaozhao Foster, Celia E. Miao, David Li, Annie S. Zhang, Xiaoman Gavin, Ruth M. Forde, Sorcha D. Germain, Gail Carpenter, Susan Rosadini, Charles V. Gritsman, Kira Chae, Jae Jin Hampton, Randolph Silverman, Neal Gravallese, Ellen M. Kagan, Jonathan C. Fitzgerald, Katherine A. Kastner, Daniel L. Golenbock, Douglas T. Bergo, Martin O. Wang, Donghai |
author_facet | Akula, Murali K. Shi, Man Jiang, Zhaozhao Foster, Celia E. Miao, David Li, Annie S. Zhang, Xiaoman Gavin, Ruth M. Forde, Sorcha D. Germain, Gail Carpenter, Susan Rosadini, Charles V. Gritsman, Kira Chae, Jae Jin Hampton, Randolph Silverman, Neal Gravallese, Ellen M. Kagan, Jonathan C. Fitzgerald, Katherine A. Kastner, Daniel L. Golenbock, Douglas T. Bergo, Martin O. Wang, Donghai |
author_sort | Akula, Murali K. |
collection | PubMed |
description | Deficiency of mevalonate kinase (MVK) causes systemic inflammation. However, the molecular mechanisms linking the mevalonate pathway to inflammation remain obscure. Geranylgeranyl pyrophosphate (GGPP), a non-sterol intermediate of the mevalonate pathway, is the substrate for protein geranylgeranylation, protein post-translational modification catalyzed by protein geranylgeranyl transferase I (GGTase I). Pyrin is an innate immune sensor that forms an active inflammasome in response to bacterial toxins. Mutations in MEFV (encoding human PYRIN) cause autoinflammatory Familial Mediterranean Fever (FMF) syndrome. Here, we show that protein geranylgeranylation enables Toll-like receptor (TLR)-induced phosphatidylinositol-3-OH kinase PI(3)K) activation by promoting the interaction between the small GTPase Kras and the PI(3)K catalytic subunit p110δ. Macrophages deficient for GGTase I or p110δ exhibited constitutive interleukin-1β release that was MEFV-dependent, but NLRP3-, AIM2- and NLRC4- inflammasome independent. In the absence of protein geranylgeranylation, compromised PI(3)K activity allows for an unchecked TLR-induced inflammatory responses and constitutive activation of the Pyrin inflammasome. |
format | Online Article Text |
id | pubmed-4955724 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
record_format | MEDLINE/PubMed |
spelling | pubmed-49557242016-12-06 Control of the innate immune response by the mevalonate pathway Akula, Murali K. Shi, Man Jiang, Zhaozhao Foster, Celia E. Miao, David Li, Annie S. Zhang, Xiaoman Gavin, Ruth M. Forde, Sorcha D. Germain, Gail Carpenter, Susan Rosadini, Charles V. Gritsman, Kira Chae, Jae Jin Hampton, Randolph Silverman, Neal Gravallese, Ellen M. Kagan, Jonathan C. Fitzgerald, Katherine A. Kastner, Daniel L. Golenbock, Douglas T. Bergo, Martin O. Wang, Donghai Nat Immunol Article Deficiency of mevalonate kinase (MVK) causes systemic inflammation. However, the molecular mechanisms linking the mevalonate pathway to inflammation remain obscure. Geranylgeranyl pyrophosphate (GGPP), a non-sterol intermediate of the mevalonate pathway, is the substrate for protein geranylgeranylation, protein post-translational modification catalyzed by protein geranylgeranyl transferase I (GGTase I). Pyrin is an innate immune sensor that forms an active inflammasome in response to bacterial toxins. Mutations in MEFV (encoding human PYRIN) cause autoinflammatory Familial Mediterranean Fever (FMF) syndrome. Here, we show that protein geranylgeranylation enables Toll-like receptor (TLR)-induced phosphatidylinositol-3-OH kinase PI(3)K) activation by promoting the interaction between the small GTPase Kras and the PI(3)K catalytic subunit p110δ. Macrophages deficient for GGTase I or p110δ exhibited constitutive interleukin-1β release that was MEFV-dependent, but NLRP3-, AIM2- and NLRC4- inflammasome independent. In the absence of protein geranylgeranylation, compromised PI(3)K activity allows for an unchecked TLR-induced inflammatory responses and constitutive activation of the Pyrin inflammasome. 2016-06-06 2016-08 /pmc/articles/PMC4955724/ /pubmed/27270400 http://dx.doi.org/10.1038/ni.3487 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Akula, Murali K. Shi, Man Jiang, Zhaozhao Foster, Celia E. Miao, David Li, Annie S. Zhang, Xiaoman Gavin, Ruth M. Forde, Sorcha D. Germain, Gail Carpenter, Susan Rosadini, Charles V. Gritsman, Kira Chae, Jae Jin Hampton, Randolph Silverman, Neal Gravallese, Ellen M. Kagan, Jonathan C. Fitzgerald, Katherine A. Kastner, Daniel L. Golenbock, Douglas T. Bergo, Martin O. Wang, Donghai Control of the innate immune response by the mevalonate pathway |
title | Control of the innate immune response by the mevalonate pathway |
title_full | Control of the innate immune response by the mevalonate pathway |
title_fullStr | Control of the innate immune response by the mevalonate pathway |
title_full_unstemmed | Control of the innate immune response by the mevalonate pathway |
title_short | Control of the innate immune response by the mevalonate pathway |
title_sort | control of the innate immune response by the mevalonate pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955724/ https://www.ncbi.nlm.nih.gov/pubmed/27270400 http://dx.doi.org/10.1038/ni.3487 |
work_keys_str_mv | AT akulamuralik controloftheinnateimmuneresponsebythemevalonatepathway AT shiman controloftheinnateimmuneresponsebythemevalonatepathway AT jiangzhaozhao controloftheinnateimmuneresponsebythemevalonatepathway AT fosterceliae controloftheinnateimmuneresponsebythemevalonatepathway AT miaodavid controloftheinnateimmuneresponsebythemevalonatepathway AT liannies controloftheinnateimmuneresponsebythemevalonatepathway AT zhangxiaoman controloftheinnateimmuneresponsebythemevalonatepathway AT gavinruthm controloftheinnateimmuneresponsebythemevalonatepathway AT fordesorchad controloftheinnateimmuneresponsebythemevalonatepathway AT germaingail controloftheinnateimmuneresponsebythemevalonatepathway AT carpentersusan controloftheinnateimmuneresponsebythemevalonatepathway AT rosadinicharlesv controloftheinnateimmuneresponsebythemevalonatepathway AT gritsmankira controloftheinnateimmuneresponsebythemevalonatepathway AT chaejaejin controloftheinnateimmuneresponsebythemevalonatepathway AT hamptonrandolph controloftheinnateimmuneresponsebythemevalonatepathway AT silvermanneal controloftheinnateimmuneresponsebythemevalonatepathway AT gravalleseellenm controloftheinnateimmuneresponsebythemevalonatepathway AT kaganjonathanc controloftheinnateimmuneresponsebythemevalonatepathway AT fitzgeraldkatherinea controloftheinnateimmuneresponsebythemevalonatepathway AT kastnerdaniell controloftheinnateimmuneresponsebythemevalonatepathway AT golenbockdouglast controloftheinnateimmuneresponsebythemevalonatepathway AT bergomartino controloftheinnateimmuneresponsebythemevalonatepathway AT wangdonghai controloftheinnateimmuneresponsebythemevalonatepathway |